Vertex Pharmaceuticals (VRTX) Construction in Progress (2011 - 2012)
Vertex Pharmaceuticals (VRTX) posted quarterly Construction in Progress of $223.1 million for Q3 2012, up 305.12% quarter-over-quarter from $55.1 million in Q4 2011.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Construction in Progress (2011 - 2012) Analysis & Trends
Vertex Pharmaceuticals' Construction in Progress history runs 2 years deep, the most recent figure standing at $223.1 million for Q3 2012.
- In Q3 2012, Construction in Progress changed N/A year-over-year to $223.1 million; the TTM figure through Sep 2012 stood at $223.1 million (changed N/A YoY), while the FY2011 annual figure was $55.1 million, changed N/A from the prior year.
- Construction in Progress for Q3 2012 stood at $223.1 million, up from $55.1 million in the prior quarter.
- The five-year high for Construction in Progress was $223.1 million in Q3 2012, with the low at $55.1 million in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 152.67 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | - |